<ѻý>First Detailed Look at COVID Vaccine Skin Reactionsѻý> Mostly mild, self-limiting reactions and no serious adverse reactions May 05, 2021
<ѻý>Rapid Improvement in Atopic Dermatitis With New JAK1 Inhibitorѻý> Plus: First-in-class drug shows promise in AD, BTK inhibitor active in pemphigus May 03, 2021
<ѻý>Topical JAK Inhibitor Shows Promise in Vitiligoѻý> Half of patients had 90% improvement after 2 years of treatment Apr 30, 2021
<ѻý>High Rate of Hyperhidrosis Relief With Topical Agentѻý> Benefit for 86% of patients treated with sofpironium bromide Apr 29, 2021
<ѻý>Rapid Improvement in Atopic Dermatitis With Topical JAK Inhibitorѻý> Disease activity index improved as early as week 1 with delgocitinib cream Apr 27, 2021
<ѻý>Significant Improvement in Hand Eczema With Pan-JAK Inhibitorѻý> Disease activity indicators reduced, no safety signals with gusacitinib versus placebo Apr 26, 2021
<ѻý>Big Win in Psoriasis for Dual IL-17A/17F Inhibitorѻý> Significant differences in clearance with bimekizumab vs secukinumab at all time points Apr 23, 2021
<ѻý>Op-Ed: Dermatology Needs Lower Costs and Better Careѻý> A proposal for value-based care Apr 21, 2021
<ѻý>Nivolumab Alone Prevails in Resected Melanomaѻý> Adding ipilimumab in adjuvant setting failed to improve relapse-free survival Apr 11, 2021
<ѻý>For Enthesitis in Psoriatic Arthritis, Target IL-23ѻý> Targeted agent provides relief for many PsA patients Apr 08, 2021
<ѻý>COVID Triggers Novel Infectious Skin Condition in Teenѻý> Mild case led to unusual effects a week later Apr 07, 2021
<ѻý>JAK Inhibitor Promising in Psoriatic Arthritisѻý> Oral agent noninferior to adalimumab in joint symptoms Apr 01, 2021
<ѻý>Using the Skin Microbiome to Control Atopic Dermatitisѻý> Bacteria-based therapy shows promise in proof-of-concept trial Mar 01, 2021
<ѻý>Young Hidradenitis Suppurativa Patients See Lags in Careѻý> Diagnosis typically came years after disease onset; providers claim lack of knowledge on HS pain Feb 24, 2021
<ѻý>Want Data on Recently Approved Actinic Keratosis Drug? Here You Goѻý> Phase III trial now published in full for topical anti-proliferative treatment Feb 10, 2021
<ѻý>Monoclonal Antibody Highly Effective in Phase III Psoriasis Trialѻý> Beats ustekinumab, but main side effect was oral candidiasis Feb 05, 2021
<ѻý>Brain Tumor Risk Upped With Synthetic Progestogenѻý> Absolute risk still low, however, and product not currently approved in U.S. Feb 03, 2021
<ѻý>High Potassium No Threat With Spironolactoneѻý> Despite guidelines, many still monitoring K levels in young women with acne, researchers find Jan 27, 2021
<ѻý>Masculinizing Hormone Therapy Tied to Acne in Transmenѻý> Acne also linked with depression and anxiety; Accutane may be treatment option Jan 20, 2021
<ѻý>Derm Symptoms Signal MIS-C in Kidsѻý> Case series shows mucocutaneous findings in most children Dec 09, 2020
<ѻý>Renewed Concerns About Finasteride and Mental Healthѻý> Database study links popular alopecia treatment with increased risks of suicidality, depression Nov 27, 2020
<ѻý>Eva Mendes Gets Mono-Threadingѻý> A look at the movie star's recent beauty procedure Nov 24, 2020
<ѻý>More Evidence for Ligelizumab in Chronic Hivesѻý> Anti-IgE drug showed improved activity in omalizumab-treated patients with inadequate symptom control Nov 17, 2020
<ѻý>Watch for Suicidality in Men on Propeciaѻý> Analysis found high number of psychological-related reports Nov 11, 2020
<ѻý>TYK2 Inhibition Promising in Psoriatic Arthritisѻý> Phase II study found significant benefits for two doses of novel agent Nov 10, 2020
<ѻý>Gut Bacteria for Psoriasis; Long-Term Hair Growth; COVID and STDsѻý> Selected presentations from the European Academy of Dermatology and Venereology virtual conference Nov 05, 2020
<ѻý>Nonsteroidal Topical, Nanodrug Active in Psoriasisѻý> Selected presentations from the European Academy of Dermatology and Venereology meeting Nov 04, 2020
<ѻý>Atopic Dermatitis: New Topical Agent, Durable Results With Oralsѻý> Selected abstracts from the European Academy of Dermatology and Venereology Virtual Conference Nov 02, 2020
<ѻý>First-Ever Positive Phase III Trial in Epidermolysis Bullosaѻý> Faster wound healing with oleogel-S10, particularly in most common form of EB Nov 01, 2020
<ѻý>Add Skin Conditions to COVID-19 Long-Hauler Effectsѻý> Persistence beyond 60 days in some cases, especially with pernio/chilblains Oct 30, 2020
<ѻý>Melanoma Survival Benefit Sustained at 5 Years With Adjuvant Comboѻý> Dabrafenib plus trametinib cut relapse risk in half Sep 02, 2020
<ѻý>Demographics Make a Difference in Common Skin Cancersѻý> Study looks at epidemiology of basal versus squamous cell carcinomas Aug 26, 2020
<ѻý>Calcineurin Blockers for Eczema: No Cancer Signal in Big Studyѻý> "Clinicians can use this evidence to counsel and reassure patients" Aug 12, 2020
<ѻý>New Insights Into Radiation-Induced Hair Lossѻý> Total dose and fraction size matter, minoxidil may spur regrowth Aug 05, 2020
<ѻý>Skin Rashes a Clue to COVID-19 Vascular Diseaseѻý> Certain skin manifestations tied to coagulopathy in the sickest patients Aug 05, 2020
<ѻý>Triplet OK'd as First-Line Therapy in Melanomaѻý> Immunotherapy plus targeted combo nets FDA approval in BRAF-mutant population Jul 31, 2020
<ѻý>DPP-4 Inhibitors Tied to Blistering Skin Conditionѻý> Increased risk for bullous pemphigoid modified by patient age, race Jul 22, 2020
<ѻý>Targeting IL-23 Relieves Multiple Symptoms in PsAѻý> Both enthesitis and dactylitis improved with guselkumab treatment in psoriatic arthritis Jul 21, 2020
<ѻý>COVID-19 May Manifest in the Mouth in Some Patientsѻý> Pay attention to those with a rash, small case series from Spain advises Jul 15, 2020
<ѻý>Psoriasis Cream Succeeds in Early Trialѻý> PDE-4 inhibitor helped clear plaque psoriasis in 6 weeks Jul 15, 2020